nodes	percent_of_prediction	percent_of_DWPC	metapath
Palonosetron—HTR3A—myenteric nerve plexus—stomach cancer	0.107	0.448	CbGeAlD
Palonosetron—HTR3A—vagus nerve—stomach cancer	0.0712	0.299	CbGeAlD
Palonosetron—HTR3A—hematopoietic system—stomach cancer	0.0116	0.0488	CbGeAlD
Palonosetron—HTR3A—digestive system—stomach cancer	0.00808	0.0339	CbGeAlD
Palonosetron—CYP1A2—Fluorouracil—stomach cancer	0.00769	0.369	CbGbCtD
Palonosetron—CYP1A2—hematopoietic system—stomach cancer	0.006	0.0252	CbGeAlD
Palonosetron—CYP3A4—hematopoietic system—stomach cancer	0.00434	0.0182	CbGeAlD
Palonosetron—CYP2D6—hematopoietic system—stomach cancer	0.00427	0.0179	CbGeAlD
Palonosetron—CYP3A4—Irinotecan—stomach cancer	0.0042	0.201	CbGbCtD
Palonosetron—CYP1A2—digestive system—stomach cancer	0.00417	0.0175	CbGeAlD
Palonosetron—CYP2D6—Doxorubicin—stomach cancer	0.00361	0.173	CbGbCtD
Palonosetron—CYP1A2—endocrine gland—stomach cancer	0.00345	0.0145	CbGeAlD
Palonosetron—CYP1A2—liver—stomach cancer	0.00311	0.013	CbGeAlD
Palonosetron—CYP3A4—Docetaxel—stomach cancer	0.00308	0.148	CbGbCtD
Palonosetron—CYP3A4—digestive system—stomach cancer	0.00302	0.0127	CbGeAlD
Palonosetron—CYP2D6—digestive system—stomach cancer	0.00297	0.0125	CbGeAlD
Palonosetron—CYP3A4—endocrine gland—stomach cancer	0.0025	0.0105	CbGeAlD
Palonosetron—CYP2D6—endocrine gland—stomach cancer	0.00246	0.0103	CbGeAlD
Palonosetron—CYP3A4—Doxorubicin—stomach cancer	0.00229	0.11	CbGbCtD
Palonosetron—CYP3A4—liver—stomach cancer	0.00225	0.00944	CbGeAlD
Palonosetron—CYP2D6—liver—stomach cancer	0.00221	0.00928	CbGeAlD
Palonosetron—Discomfort—Capecitabine—stomach cancer	0.000886	0.0012	CcSEcCtD
Palonosetron—Epistaxis—Epirubicin—stomach cancer	0.000886	0.0012	CcSEcCtD
Palonosetron—Urethral disorder—Methotrexate—stomach cancer	0.000883	0.00119	CcSEcCtD
Palonosetron—Infection—Docetaxel—stomach cancer	0.000882	0.00119	CcSEcCtD
Palonosetron—Sinusitis—Epirubicin—stomach cancer	0.000881	0.00119	CcSEcCtD
Palonosetron—Hyperglycaemia—Doxorubicin—stomach cancer	0.000879	0.00119	CcSEcCtD
Palonosetron—Diarrhoea—Irinotecan—stomach cancer	0.000879	0.00119	CcSEcCtD
Palonosetron—Dry mouth—Capecitabine—stomach cancer	0.000877	0.00118	CcSEcCtD
Palonosetron—Shock—Docetaxel—stomach cancer	0.000873	0.00118	CcSEcCtD
Palonosetron—Nervous system disorder—Docetaxel—stomach cancer	0.000871	0.00118	CcSEcCtD
Palonosetron—Pruritus—Fluorouracil—stomach cancer	0.00087	0.00117	CcSEcCtD
Palonosetron—Tachycardia—Docetaxel—stomach cancer	0.000866	0.00117	CcSEcCtD
Palonosetron—Skin disorder—Docetaxel—stomach cancer	0.000862	0.00116	CcSEcCtD
Palonosetron—Bradycardia—Epirubicin—stomach cancer	0.000858	0.00116	CcSEcCtD
Palonosetron—Infection—Capecitabine—stomach cancer	0.000854	0.00115	CcSEcCtD
Palonosetron—Dizziness—Irinotecan—stomach cancer	0.000849	0.00115	CcSEcCtD
Palonosetron—Anorexia—Docetaxel—stomach cancer	0.000846	0.00114	CcSEcCtD
Palonosetron—Shock—Capecitabine—stomach cancer	0.000846	0.00114	CcSEcCtD
Palonosetron—Nervous system disorder—Capecitabine—stomach cancer	0.000843	0.00114	CcSEcCtD
Palonosetron—Eye disorder—Methotrexate—stomach cancer	0.000842	0.00114	CcSEcCtD
Palonosetron—Diarrhoea—Fluorouracil—stomach cancer	0.000842	0.00114	CcSEcCtD
Palonosetron—Tinnitus—Methotrexate—stomach cancer	0.00084	0.00113	CcSEcCtD
Palonosetron—Tachycardia—Capecitabine—stomach cancer	0.000839	0.00113	CcSEcCtD
Palonosetron—Cardiac disorder—Methotrexate—stomach cancer	0.000836	0.00113	CcSEcCtD
Palonosetron—Skin disorder—Capecitabine—stomach cancer	0.000835	0.00113	CcSEcCtD
Palonosetron—Urinary tract disorder—Epirubicin—stomach cancer	0.000832	0.00112	CcSEcCtD
Palonosetron—Hypotension—Docetaxel—stomach cancer	0.00083	0.00112	CcSEcCtD
Palonosetron—Connective tissue disorder—Epirubicin—stomach cancer	0.000828	0.00112	CcSEcCtD
Palonosetron—Urethral disorder—Epirubicin—stomach cancer	0.000826	0.00112	CcSEcCtD
Palonosetron—Hepatobiliary disease—Doxorubicin—stomach cancer	0.000822	0.00111	CcSEcCtD
Palonosetron—Epistaxis—Doxorubicin—stomach cancer	0.000819	0.00111	CcSEcCtD
Palonosetron—Anorexia—Capecitabine—stomach cancer	0.000819	0.00111	CcSEcCtD
Palonosetron—Angiopathy—Methotrexate—stomach cancer	0.000817	0.0011	CcSEcCtD
Palonosetron—Vomiting—Irinotecan—stomach cancer	0.000816	0.0011	CcSEcCtD
Palonosetron—Sinusitis—Doxorubicin—stomach cancer	0.000815	0.0011	CcSEcCtD
Palonosetron—Immune system disorder—Methotrexate—stomach cancer	0.000813	0.0011	CcSEcCtD
Palonosetron—Dizziness—Fluorouracil—stomach cancer	0.000813	0.0011	CcSEcCtD
Palonosetron—Mediastinal disorder—Methotrexate—stomach cancer	0.000812	0.0011	CcSEcCtD
Palonosetron—Rash—Irinotecan—stomach cancer	0.00081	0.00109	CcSEcCtD
Palonosetron—Dermatitis—Irinotecan—stomach cancer	0.000809	0.00109	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000809	0.00109	CcSEcCtD
Palonosetron—Chills—Methotrexate—stomach cancer	0.000808	0.00109	CcSEcCtD
Palonosetron—Headache—Irinotecan—stomach cancer	0.000804	0.00109	CcSEcCtD
Palonosetron—Hypotension—Capecitabine—stomach cancer	0.000803	0.00108	CcSEcCtD
Palonosetron—Insomnia—Docetaxel—stomach cancer	0.000803	0.00108	CcSEcCtD
Palonosetron—Paraesthesia—Docetaxel—stomach cancer	0.000797	0.00108	CcSEcCtD
Palonosetron—Alopecia—Methotrexate—stomach cancer	0.000796	0.00107	CcSEcCtD
Palonosetron—Bradycardia—Doxorubicin—stomach cancer	0.000794	0.00107	CcSEcCtD
Palonosetron—Dyspnoea—Docetaxel—stomach cancer	0.000791	0.00107	CcSEcCtD
Palonosetron—Somnolence—Docetaxel—stomach cancer	0.000789	0.00107	CcSEcCtD
Palonosetron—Mental disorder—Methotrexate—stomach cancer	0.000789	0.00107	CcSEcCtD
Palonosetron—Eye disorder—Epirubicin—stomach cancer	0.000788	0.00106	CcSEcCtD
Palonosetron—Tinnitus—Epirubicin—stomach cancer	0.000786	0.00106	CcSEcCtD
Palonosetron—Erythema—Methotrexate—stomach cancer	0.000784	0.00106	CcSEcCtD
Palonosetron—Malnutrition—Methotrexate—stomach cancer	0.000784	0.00106	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000783	0.00106	CcSEcCtD
Palonosetron—Cardiac disorder—Epirubicin—stomach cancer	0.000782	0.00106	CcSEcCtD
Palonosetron—Vomiting—Fluorouracil—stomach cancer	0.000782	0.00106	CcSEcCtD
Palonosetron—Dyspepsia—Docetaxel—stomach cancer	0.000781	0.00105	CcSEcCtD
Palonosetron—Insomnia—Capecitabine—stomach cancer	0.000777	0.00105	CcSEcCtD
Palonosetron—Rash—Fluorouracil—stomach cancer	0.000775	0.00105	CcSEcCtD
Palonosetron—Dermatitis—Fluorouracil—stomach cancer	0.000775	0.00105	CcSEcCtD
Palonosetron—Paraesthesia—Capecitabine—stomach cancer	0.000772	0.00104	CcSEcCtD
Palonosetron—Decreased appetite—Docetaxel—stomach cancer	0.000772	0.00104	CcSEcCtD
Palonosetron—Headache—Fluorouracil—stomach cancer	0.000771	0.00104	CcSEcCtD
Palonosetron—Urinary tract disorder—Doxorubicin—stomach cancer	0.00077	0.00104	CcSEcCtD
Palonosetron—Dysgeusia—Methotrexate—stomach cancer	0.000768	0.00104	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000766	0.00103	CcSEcCtD
Palonosetron—Connective tissue disorder—Doxorubicin—stomach cancer	0.000766	0.00103	CcSEcCtD
Palonosetron—Dyspnoea—Capecitabine—stomach cancer	0.000766	0.00103	CcSEcCtD
Palonosetron—Fatigue—Docetaxel—stomach cancer	0.000765	0.00103	CcSEcCtD
Palonosetron—Angiopathy—Epirubicin—stomach cancer	0.000765	0.00103	CcSEcCtD
Palonosetron—Urethral disorder—Doxorubicin—stomach cancer	0.000764	0.00103	CcSEcCtD
Palonosetron—Nausea—Irinotecan—stomach cancer	0.000763	0.00103	CcSEcCtD
Palonosetron—Immune system disorder—Epirubicin—stomach cancer	0.000761	0.00103	CcSEcCtD
Palonosetron—Mediastinal disorder—Epirubicin—stomach cancer	0.00076	0.00103	CcSEcCtD
Palonosetron—Pain—Docetaxel—stomach cancer	0.000759	0.00102	CcSEcCtD
Palonosetron—Constipation—Docetaxel—stomach cancer	0.000759	0.00102	CcSEcCtD
Palonosetron—Dyspepsia—Capecitabine—stomach cancer	0.000757	0.00102	CcSEcCtD
Palonosetron—Chills—Epirubicin—stomach cancer	0.000756	0.00102	CcSEcCtD
Palonosetron—Arrhythmia—Epirubicin—stomach cancer	0.000753	0.00102	CcSEcCtD
Palonosetron—Decreased appetite—Capecitabine—stomach cancer	0.000747	0.00101	CcSEcCtD
Palonosetron—Alopecia—Epirubicin—stomach cancer	0.000745	0.00101	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000742	0.001	CcSEcCtD
Palonosetron—Fatigue—Capecitabine—stomach cancer	0.000741	0.001	CcSEcCtD
Palonosetron—Mental disorder—Epirubicin—stomach cancer	0.000738	0.000997	CcSEcCtD
Palonosetron—Constipation—Capecitabine—stomach cancer	0.000735	0.000992	CcSEcCtD
Palonosetron—Pain—Capecitabine—stomach cancer	0.000735	0.000992	CcSEcCtD
Palonosetron—Erythema—Epirubicin—stomach cancer	0.000734	0.000991	CcSEcCtD
Palonosetron—Malnutrition—Epirubicin—stomach cancer	0.000734	0.000991	CcSEcCtD
Palonosetron—Nausea—Fluorouracil—stomach cancer	0.000731	0.000986	CcSEcCtD
Palonosetron—Eye disorder—Doxorubicin—stomach cancer	0.000729	0.000984	CcSEcCtD
Palonosetron—Tinnitus—Doxorubicin—stomach cancer	0.000727	0.000982	CcSEcCtD
Palonosetron—Gastrointestinal pain—Docetaxel—stomach cancer	0.000726	0.00098	CcSEcCtD
Palonosetron—Anaemia—Methotrexate—stomach cancer	0.000725	0.000978	CcSEcCtD
Palonosetron—Cardiac disorder—Doxorubicin—stomach cancer	0.000724	0.000977	CcSEcCtD
Palonosetron—Flatulence—Epirubicin—stomach cancer	0.000723	0.000976	CcSEcCtD
Palonosetron—Dysgeusia—Epirubicin—stomach cancer	0.000718	0.00097	CcSEcCtD
Palonosetron—Angiopathy—Doxorubicin—stomach cancer	0.000708	0.000955	CcSEcCtD
Palonosetron—Immune system disorder—Doxorubicin—stomach cancer	0.000704	0.000951	CcSEcCtD
Palonosetron—Gastrointestinal pain—Capecitabine—stomach cancer	0.000703	0.000949	CcSEcCtD
Palonosetron—Mediastinal disorder—Doxorubicin—stomach cancer	0.000703	0.000949	CcSEcCtD
Palonosetron—Abdominal pain—Docetaxel—stomach cancer	0.000702	0.000947	CcSEcCtD
Palonosetron—Body temperature increased—Docetaxel—stomach cancer	0.000702	0.000947	CcSEcCtD
Palonosetron—Chills—Doxorubicin—stomach cancer	0.0007	0.000945	CcSEcCtD
Palonosetron—Arrhythmia—Doxorubicin—stomach cancer	0.000697	0.000941	CcSEcCtD
Palonosetron—Alopecia—Doxorubicin—stomach cancer	0.000689	0.00093	CcSEcCtD
Palonosetron—Mental disorder—Doxorubicin—stomach cancer	0.000683	0.000922	CcSEcCtD
Palonosetron—Abdominal pain—Capecitabine—stomach cancer	0.000679	0.000917	CcSEcCtD
Palonosetron—Body temperature increased—Capecitabine—stomach cancer	0.000679	0.000917	CcSEcCtD
Palonosetron—Convulsion—Methotrexate—stomach cancer	0.000679	0.000917	CcSEcCtD
Palonosetron—Erythema—Doxorubicin—stomach cancer	0.000679	0.000916	CcSEcCtD
Palonosetron—Malnutrition—Doxorubicin—stomach cancer	0.000679	0.000916	CcSEcCtD
Palonosetron—Anaemia—Epirubicin—stomach cancer	0.000678	0.000915	CcSEcCtD
Palonosetron—Flatulence—Doxorubicin—stomach cancer	0.000669	0.000903	CcSEcCtD
Palonosetron—Myalgia—Methotrexate—stomach cancer	0.000667	0.000901	CcSEcCtD
Palonosetron—Arthralgia—Methotrexate—stomach cancer	0.000667	0.000901	CcSEcCtD
Palonosetron—Dysgeusia—Doxorubicin—stomach cancer	0.000665	0.000897	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000663	0.000895	CcSEcCtD
Palonosetron—Discomfort—Methotrexate—stomach cancer	0.000659	0.00089	CcSEcCtD
Palonosetron—Hypersensitivity—Docetaxel—stomach cancer	0.000654	0.000883	CcSEcCtD
Palonosetron—Anaphylactic shock—Methotrexate—stomach cancer	0.00064	0.000864	CcSEcCtD
Palonosetron—Asthenia—Docetaxel—stomach cancer	0.000637	0.00086	CcSEcCtD
Palonosetron—Convulsion—Epirubicin—stomach cancer	0.000636	0.000858	CcSEcCtD
Palonosetron—Infection—Methotrexate—stomach cancer	0.000636	0.000858	CcSEcCtD
Palonosetron—Hypertension—Epirubicin—stomach cancer	0.000633	0.000855	CcSEcCtD
Palonosetron—Hypersensitivity—Capecitabine—stomach cancer	0.000633	0.000855	CcSEcCtD
Palonosetron—Pruritus—Docetaxel—stomach cancer	0.000628	0.000848	CcSEcCtD
Palonosetron—Nervous system disorder—Methotrexate—stomach cancer	0.000627	0.000847	CcSEcCtD
Palonosetron—Anaemia—Doxorubicin—stomach cancer	0.000627	0.000847	CcSEcCtD
Palonosetron—Arthralgia—Epirubicin—stomach cancer	0.000625	0.000843	CcSEcCtD
Palonosetron—Myalgia—Epirubicin—stomach cancer	0.000625	0.000843	CcSEcCtD
Palonosetron—Anxiety—Epirubicin—stomach cancer	0.000622	0.00084	CcSEcCtD
Palonosetron—Skin disorder—Methotrexate—stomach cancer	0.000621	0.000839	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.00062	0.000837	CcSEcCtD
Palonosetron—Discomfort—Epirubicin—stomach cancer	0.000617	0.000833	CcSEcCtD
Palonosetron—Asthenia—Capecitabine—stomach cancer	0.000617	0.000833	CcSEcCtD
Palonosetron—Dry mouth—Epirubicin—stomach cancer	0.000611	0.000825	CcSEcCtD
Palonosetron—Anorexia—Methotrexate—stomach cancer	0.00061	0.000823	CcSEcCtD
Palonosetron—Pruritus—Capecitabine—stomach cancer	0.000608	0.000821	CcSEcCtD
Palonosetron—Diarrhoea—Docetaxel—stomach cancer	0.000607	0.00082	CcSEcCtD
Palonosetron—Anaphylactic shock—Epirubicin—stomach cancer	0.000599	0.000808	CcSEcCtD
Palonosetron—Hypotension—Methotrexate—stomach cancer	0.000598	0.000807	CcSEcCtD
Palonosetron—Infection—Epirubicin—stomach cancer	0.000595	0.000803	CcSEcCtD
Palonosetron—Shock—Epirubicin—stomach cancer	0.000589	0.000795	CcSEcCtD
Palonosetron—Convulsion—Doxorubicin—stomach cancer	0.000588	0.000794	CcSEcCtD
Palonosetron—Diarrhoea—Capecitabine—stomach cancer	0.000588	0.000794	CcSEcCtD
Palonosetron—Nervous system disorder—Epirubicin—stomach cancer	0.000587	0.000793	CcSEcCtD
Palonosetron—Dizziness—Docetaxel—stomach cancer	0.000587	0.000793	CcSEcCtD
Palonosetron—Hypertension—Doxorubicin—stomach cancer	0.000586	0.000791	CcSEcCtD
Palonosetron—Tachycardia—Epirubicin—stomach cancer	0.000584	0.000789	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000583	0.000787	CcSEcCtD
Palonosetron—Skin disorder—Epirubicin—stomach cancer	0.000582	0.000785	CcSEcCtD
Palonosetron—Insomnia—Methotrexate—stomach cancer	0.000579	0.000781	CcSEcCtD
Palonosetron—Arthralgia—Doxorubicin—stomach cancer	0.000578	0.00078	CcSEcCtD
Palonosetron—Myalgia—Doxorubicin—stomach cancer	0.000578	0.00078	CcSEcCtD
Palonosetron—Anxiety—Doxorubicin—stomach cancer	0.000576	0.000778	CcSEcCtD
Palonosetron—Paraesthesia—Methotrexate—stomach cancer	0.000575	0.000776	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000574	0.000775	CcSEcCtD
Palonosetron—Discomfort—Doxorubicin—stomach cancer	0.000571	0.000771	CcSEcCtD
Palonosetron—Anorexia—Epirubicin—stomach cancer	0.000571	0.000771	CcSEcCtD
Palonosetron—Dyspnoea—Methotrexate—stomach cancer	0.00057	0.00077	CcSEcCtD
Palonosetron—Somnolence—Methotrexate—stomach cancer	0.000569	0.000768	CcSEcCtD
Palonosetron—Dizziness—Capecitabine—stomach cancer	0.000568	0.000767	CcSEcCtD
Palonosetron—Dry mouth—Doxorubicin—stomach cancer	0.000565	0.000763	CcSEcCtD
Palonosetron—Vomiting—Docetaxel—stomach cancer	0.000564	0.000762	CcSEcCtD
Palonosetron—Dyspepsia—Methotrexate—stomach cancer	0.000563	0.00076	CcSEcCtD
Palonosetron—Rash—Docetaxel—stomach cancer	0.00056	0.000756	CcSEcCtD
Palonosetron—Hypotension—Epirubicin—stomach cancer	0.00056	0.000755	CcSEcCtD
Palonosetron—Dermatitis—Docetaxel—stomach cancer	0.000559	0.000755	CcSEcCtD
Palonosetron—Decreased appetite—Methotrexate—stomach cancer	0.000556	0.000751	CcSEcCtD
Palonosetron—Headache—Docetaxel—stomach cancer	0.000556	0.000751	CcSEcCtD
Palonosetron—Anaphylactic shock—Doxorubicin—stomach cancer	0.000554	0.000748	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000552	0.000746	CcSEcCtD
Palonosetron—Fatigue—Methotrexate—stomach cancer	0.000552	0.000745	CcSEcCtD
Palonosetron—Infection—Doxorubicin—stomach cancer	0.00055	0.000743	CcSEcCtD
Palonosetron—Pain—Methotrexate—stomach cancer	0.000547	0.000739	CcSEcCtD
Palonosetron—Vomiting—Capecitabine—stomach cancer	0.000546	0.000738	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000546	0.000737	CcSEcCtD
Palonosetron—Shock—Doxorubicin—stomach cancer	0.000545	0.000736	CcSEcCtD
Palonosetron—Nervous system disorder—Doxorubicin—stomach cancer	0.000543	0.000734	CcSEcCtD
Palonosetron—Rash—Capecitabine—stomach cancer	0.000542	0.000732	CcSEcCtD
Palonosetron—Insomnia—Epirubicin—stomach cancer	0.000542	0.000731	CcSEcCtD
Palonosetron—Dermatitis—Capecitabine—stomach cancer	0.000541	0.000731	CcSEcCtD
Palonosetron—Tachycardia—Doxorubicin—stomach cancer	0.000541	0.00073	CcSEcCtD
Palonosetron—Headache—Capecitabine—stomach cancer	0.000538	0.000727	CcSEcCtD
Palonosetron—Skin disorder—Doxorubicin—stomach cancer	0.000538	0.000727	CcSEcCtD
Palonosetron—Paraesthesia—Epirubicin—stomach cancer	0.000538	0.000726	CcSEcCtD
Palonosetron—Dyspnoea—Epirubicin—stomach cancer	0.000534	0.000721	CcSEcCtD
Palonosetron—Somnolence—Epirubicin—stomach cancer	0.000532	0.000719	CcSEcCtD
Palonosetron—Anorexia—Doxorubicin—stomach cancer	0.000528	0.000713	CcSEcCtD
Palonosetron—Nausea—Docetaxel—stomach cancer	0.000527	0.000712	CcSEcCtD
Palonosetron—Dyspepsia—Epirubicin—stomach cancer	0.000527	0.000712	CcSEcCtD
Palonosetron—Gastrointestinal pain—Methotrexate—stomach cancer	0.000523	0.000706	CcSEcCtD
Palonosetron—Decreased appetite—Epirubicin—stomach cancer	0.000521	0.000703	CcSEcCtD
Palonosetron—Hypotension—Doxorubicin—stomach cancer	0.000518	0.000699	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000517	0.000698	CcSEcCtD
Palonosetron—Fatigue—Epirubicin—stomach cancer	0.000516	0.000697	CcSEcCtD
Palonosetron—Constipation—Epirubicin—stomach cancer	0.000512	0.000691	CcSEcCtD
Palonosetron—Pain—Epirubicin—stomach cancer	0.000512	0.000691	CcSEcCtD
Palonosetron—Nausea—Capecitabine—stomach cancer	0.000511	0.000689	CcSEcCtD
Palonosetron—Body temperature increased—Methotrexate—stomach cancer	0.000506	0.000683	CcSEcCtD
Palonosetron—Abdominal pain—Methotrexate—stomach cancer	0.000506	0.000683	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000505	0.000681	CcSEcCtD
Palonosetron—Insomnia—Doxorubicin—stomach cancer	0.000501	0.000677	CcSEcCtD
Palonosetron—Paraesthesia—Doxorubicin—stomach cancer	0.000497	0.000672	CcSEcCtD
Palonosetron—Dyspnoea—Doxorubicin—stomach cancer	0.000494	0.000667	CcSEcCtD
Palonosetron—Somnolence—Doxorubicin—stomach cancer	0.000493	0.000665	CcSEcCtD
Palonosetron—Gastrointestinal pain—Epirubicin—stomach cancer	0.00049	0.000661	CcSEcCtD
Palonosetron—Dyspepsia—Doxorubicin—stomach cancer	0.000488	0.000658	CcSEcCtD
Palonosetron—Decreased appetite—Doxorubicin—stomach cancer	0.000482	0.00065	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000478	0.000646	CcSEcCtD
Palonosetron—Fatigue—Doxorubicin—stomach cancer	0.000478	0.000645	CcSEcCtD
Palonosetron—Pain—Doxorubicin—stomach cancer	0.000474	0.00064	CcSEcCtD
Palonosetron—Constipation—Doxorubicin—stomach cancer	0.000474	0.00064	CcSEcCtD
Palonosetron—Abdominal pain—Epirubicin—stomach cancer	0.000473	0.000639	CcSEcCtD
Palonosetron—Body temperature increased—Epirubicin—stomach cancer	0.000473	0.000639	CcSEcCtD
Palonosetron—Hypersensitivity—Methotrexate—stomach cancer	0.000471	0.000636	CcSEcCtD
Palonosetron—Asthenia—Methotrexate—stomach cancer	0.000459	0.00062	CcSEcCtD
Palonosetron—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000453	0.000612	CcSEcCtD
Palonosetron—Pruritus—Methotrexate—stomach cancer	0.000453	0.000611	CcSEcCtD
Palonosetron—Hypersensitivity—Epirubicin—stomach cancer	0.000441	0.000596	CcSEcCtD
Palonosetron—Body temperature increased—Doxorubicin—stomach cancer	0.000438	0.000591	CcSEcCtD
Palonosetron—Abdominal pain—Doxorubicin—stomach cancer	0.000438	0.000591	CcSEcCtD
Palonosetron—Diarrhoea—Methotrexate—stomach cancer	0.000438	0.000591	CcSEcCtD
Palonosetron—Asthenia—Epirubicin—stomach cancer	0.00043	0.00058	CcSEcCtD
Palonosetron—Pruritus—Epirubicin—stomach cancer	0.000424	0.000572	CcSEcCtD
Palonosetron—Dizziness—Methotrexate—stomach cancer	0.000423	0.000571	CcSEcCtD
Palonosetron—Diarrhoea—Epirubicin—stomach cancer	0.00041	0.000553	CcSEcCtD
Palonosetron—Hypersensitivity—Doxorubicin—stomach cancer	0.000408	0.000551	CcSEcCtD
Palonosetron—Vomiting—Methotrexate—stomach cancer	0.000407	0.000549	CcSEcCtD
Palonosetron—Rash—Methotrexate—stomach cancer	0.000403	0.000545	CcSEcCtD
Palonosetron—Dermatitis—Methotrexate—stomach cancer	0.000403	0.000544	CcSEcCtD
Palonosetron—Headache—Methotrexate—stomach cancer	0.000401	0.000541	CcSEcCtD
Palonosetron—Asthenia—Doxorubicin—stomach cancer	0.000397	0.000537	CcSEcCtD
Palonosetron—Dizziness—Epirubicin—stomach cancer	0.000396	0.000535	CcSEcCtD
Palonosetron—Pruritus—Doxorubicin—stomach cancer	0.000392	0.000529	CcSEcCtD
Palonosetron—Vomiting—Epirubicin—stomach cancer	0.000381	0.000514	CcSEcCtD
Palonosetron—Nausea—Methotrexate—stomach cancer	0.00038	0.000513	CcSEcCtD
Palonosetron—Diarrhoea—Doxorubicin—stomach cancer	0.000379	0.000512	CcSEcCtD
Palonosetron—Rash—Epirubicin—stomach cancer	0.000378	0.00051	CcSEcCtD
Palonosetron—Dermatitis—Epirubicin—stomach cancer	0.000377	0.000509	CcSEcCtD
Palonosetron—Headache—Epirubicin—stomach cancer	0.000375	0.000506	CcSEcCtD
Palonosetron—Dizziness—Doxorubicin—stomach cancer	0.000366	0.000495	CcSEcCtD
Palonosetron—Nausea—Epirubicin—stomach cancer	0.000356	0.00048	CcSEcCtD
Palonosetron—Vomiting—Doxorubicin—stomach cancer	0.000352	0.000476	CcSEcCtD
Palonosetron—Rash—Doxorubicin—stomach cancer	0.000349	0.000472	CcSEcCtD
Palonosetron—Dermatitis—Doxorubicin—stomach cancer	0.000349	0.000471	CcSEcCtD
Palonosetron—Headache—Doxorubicin—stomach cancer	0.000347	0.000469	CcSEcCtD
Palonosetron—Nausea—Doxorubicin—stomach cancer	0.000329	0.000444	CcSEcCtD
